2-(2-{2-[(1H-1,2,4-triazol-1-yl)methyl]-1,3-thiazol-4-yl}ethyl)-2,3-dihydro-1H-isoindole-1,3-dione

Catalog No. :
ACFOCS622
CAS No. :
860785-68-8
Molecular Formula :
C16H13N5O2S
Molecular Weight :
339.38

IUPAC Name:2-(2-(2-((1H-1,2,4-triazol-1-yl)methyl)thiazol-4-yl)ethyl)isoindoline-1,3-dione

2-(2-{2-[(1H-1,2,4-triazol-1-yl)methyl]-1,3-thiazol-4-yl}ethyl)-2,3-dihydro-1H-isoindole-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-{2-[(1H-1,2,4-triazol-1-yl)methyl]-1,3-thiazol-4-yl}ethyl)-2,3-dihydro-1H-isoindole-1,3-dione
IUPAC Name2-(2-(2-((1H-1,2,4-triazol-1-yl)methyl)thiazol-4-yl)ethyl)isoindoline-1,3-dione
MDL No.MFCD04124549
Molecular FormulaC16H13N5O2S
Molecular Weight339.38
SMILESO=C1N(CCC2=CSC(CN3N=CN=C3)=N2)C(C4=C1C=CC=C4)=O
InChI KeyCVSHNXRNXBMXIC-UHFFFAOYSA-N
Synonym2-(2-[2-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1,3-THIAZOL-4-YL]ETHYL)-1H-ISOINDOLE-1,3(2H)-DIONE;2-(2-{2-[(1H-1,2,4-triazol-1-yl)methyl]-1,3-thiazol-4-yl}ethyl)-2,3-dihydro-1H-isoindole-1,3-dione;1H-Isoindole-1,3(2H)-dione, 2-[2-[2-(1H-1,2,4-triazol-1-ylmethyl)-4-thiazolyl]ethyl]-
CAS No.860785-68-8

Synthetic Route by SureRoute

1. ACFOCS622 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBSYZ572 route compound structure diagram
    ACBSYZ57241253-21-8 In Stock
  4. Then
  5. ACFOCS622 route product structure diagram
    ACFOCS622860785-68-8
Inquiry

2. ACFOCS622 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBSYZ572 route compound structure diagram
    ACBSYZ57241253-21-8 In Stock
  4. Then
  5. ACFOCS622 route product structure diagram
    ACFOCS622860785-68-8
Inquiry

Comments (0)